A B S T R A C T Although prostaglandins E2 and F2, have been suggested as mediators of the pulmonary hypertension seen after endotoxin infusion or during alveolar hypoxia, their precursors, the endoperoxides (prostaglandins G2 and H2) are much more potent vasoconstrictors in vitro. In this study we compared the effects of prostaglandin (PG)H2, a stable 9-methylene ether analogue of PGH2 (PGH2-A), PGE2, and PGF2a on pulmonary hemodynamics in awake sheep. The animals were prepared to allow for measurement of (a)
INTRODUCTIONThe agents mediating the pulmonary hypertension seen with alveolar hypoxia and gram-negative endotoxin infusion have not been identified. Because prostaglandins (PG)l E2 and F2, are released from the lungs during these reactions, they have been implicated as the mediators, but neither is an impressive vasoconstrictor in vitro (1, 2). In contrast, their precursors, the endoperoxides PGG2 and PGH2, are powerful vasoconstrictors, -100 times more potent in constricting isolated smooth muscle (3).Because the endoperoxides are unstable and difficult to synthesize in the large amounts needed for in vivo studies, we first used a stable 9-methylene ether analogue of PGH2 (PGH2-A; [15S] hydroxy-lla, 9a-[epoxymethano] prosta-5Z, 13E-dienoic acid, [4]) to assess the effects of endoperoxides on pulmonary vascular pressures, permeability of the lung microcirculation, and lung fluid balance in awake sheep. We then prepared PGH2, itself, in amounts large enough for brief steady-state infusions, and compared its effects to those of the analogue, PGE2 and PGF2a,.